ENDRA Life Sciences Inc (NAS:NDRA)
$ 0.1389 0.0539 (63.41%) Market Cap: 1.52 Mil Enterprise Value: 117,000.00 PE Ratio: 0 PB Ratio: 0.41 GF Score: 0/100

Q1 2020 ENDRA Life Sciences Inc Earnings Call Transcript

May 14, 2020 / 08:30PM GMT
Release Date Price: $14.31 (+13.54%)
Operator

Hello, everyone, and welcome to this ENDRA Life Sciences first quarter 2020 earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded, and to get us started with opening remarks and introductions, I am pleased to turn the floor to CFO, Mr. David Wells. Good afternoon, Mr. Wells.

David Wells
ENDRA Life Sciences Inc. - CFO

Thank you, Jim. Good afternoon and welcome to ENDRA's first quarter 2020 business update and financial conference call. We issued a press release this afternoon. For those of you who don't have a copy of the release, you can access it in the Investors section of our website at www.endrainc.com. Before we begin, please note that today's presentation includes forward-looking statements.

All statements other than statements of historical facts, including statements regarding our strategies, financial condition, operations, costs, plans and objectives, as well as anticipated results of our development and commercialization efforts,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot